Medicamen Biotech Limited is now NSE LISTED
Company is poised to launch novel oncology products in the FY 2021- 2022 in Indian region and South East Asian markets.
Haridwar Unit 1 for formulations is WHO GMP approved
ANDA filing for oncology formulations in process
1506, Chiranjiv Tower, 43 Nehru Place, New Delhi - 110019 (India)
Daily: 9:00 am - 6:00 pm
Copyright 2018 MEDICAMEN BIOTECH LIMITED © All Rights Reserved